Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses

Sigurdis Haraldsdottir, Heather Hampel, Christina Wu, Daniel Y. Weng, Peter G. Shields, Wendy L. Frankel, Xueliang Pan, Albert De La Chapelle, Richard M. Goldberg, Tanios Bekaii-Saab

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose:Mismatch repair-deficient (dMMR) colorectal cancer (CRC) is caused by Lynch syndrome (LS) in 3% and sporadic inactivation of MLH1 by hypermethylation (MLH1-hm) in 12% of cases. It is not clear whether outcomes between LS-associated and MLH1-hm CRC differ. The objective of this study was to explore differences in clinical factors and outcomes in these two groups.Methods:Patients with dMMR CRC identified by immunohistochemistry staining and treated at a single institution from 1998 to 2012 were included. MLH1-hm was established with BRAF mutational analysis or hypermethylation testing. Patients' charts were accessed for information on pathology, germ-line MMR mutation testing, and clinical course.Results:A total of 143 patients had CRC associated with LS (37 patients, 26%) or MLH1-hm (106 patients, 74%). Patients with LS were younger, more often male, presented more often with stage III disease, and had more metachronous disease than patients with MLH1-hm tumors. There was no difference in cancer-specific survival (CSS) between the groups; overall survival was longer in patients with LS, but this difference was minimal after adjusting for age and stage at diagnosis.Conclusion:CSS did not differ in LS-associated CRC compared with MLH1-hm CRC, suggesting that they carry a similar prognosis.

Original languageEnglish (US)
Pages (from-to)863-868
Number of pages6
JournalGenetics in Medicine
Volume18
Issue number9
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Colorectal Neoplasms
Survival
Neoplasms
DNA Mismatch Repair
Germ-Line Mutation
Immunohistochemistry
Pathology
Staining and Labeling

Keywords

  • colorectal cancer
  • deficient mismatch repair system
  • hypermethylation
  • Lynch syndrome
  • survival

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses. / Haraldsdottir, Sigurdis; Hampel, Heather; Wu, Christina; Weng, Daniel Y.; Shields, Peter G.; Frankel, Wendy L.; Pan, Xueliang; De La Chapelle, Albert; Goldberg, Richard M.; Bekaii-Saab, Tanios.

In: Genetics in Medicine, Vol. 18, No. 9, 01.09.2016, p. 863-868.

Research output: Contribution to journalArticle

Haraldsdottir, S, Hampel, H, Wu, C, Weng, DY, Shields, PG, Frankel, WL, Pan, X, De La Chapelle, A, Goldberg, RM & Bekaii-Saab, T 2016, 'Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses', Genetics in Medicine, vol. 18, no. 9, pp. 863-868. https://doi.org/10.1038/gim.2015.184
Haraldsdottir, Sigurdis ; Hampel, Heather ; Wu, Christina ; Weng, Daniel Y. ; Shields, Peter G. ; Frankel, Wendy L. ; Pan, Xueliang ; De La Chapelle, Albert ; Goldberg, Richard M. ; Bekaii-Saab, Tanios. / Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses. In: Genetics in Medicine. 2016 ; Vol. 18, No. 9. pp. 863-868.
@article{f6214f0b21764ceaa954b0cbb77747c3,
title = "Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses",
abstract = "Purpose:Mismatch repair-deficient (dMMR) colorectal cancer (CRC) is caused by Lynch syndrome (LS) in 3{\%} and sporadic inactivation of MLH1 by hypermethylation (MLH1-hm) in 12{\%} of cases. It is not clear whether outcomes between LS-associated and MLH1-hm CRC differ. The objective of this study was to explore differences in clinical factors and outcomes in these two groups.Methods:Patients with dMMR CRC identified by immunohistochemistry staining and treated at a single institution from 1998 to 2012 were included. MLH1-hm was established with BRAF mutational analysis or hypermethylation testing. Patients' charts were accessed for information on pathology, germ-line MMR mutation testing, and clinical course.Results:A total of 143 patients had CRC associated with LS (37 patients, 26{\%}) or MLH1-hm (106 patients, 74{\%}). Patients with LS were younger, more often male, presented more often with stage III disease, and had more metachronous disease than patients with MLH1-hm tumors. There was no difference in cancer-specific survival (CSS) between the groups; overall survival was longer in patients with LS, but this difference was minimal after adjusting for age and stage at diagnosis.Conclusion:CSS did not differ in LS-associated CRC compared with MLH1-hm CRC, suggesting that they carry a similar prognosis.",
keywords = "colorectal cancer, deficient mismatch repair system, hypermethylation, Lynch syndrome, survival",
author = "Sigurdis Haraldsdottir and Heather Hampel and Christina Wu and Weng, {Daniel Y.} and Shields, {Peter G.} and Frankel, {Wendy L.} and Xueliang Pan and {De La Chapelle}, Albert and Goldberg, {Richard M.} and Tanios Bekaii-Saab",
year = "2016",
month = "9",
day = "1",
doi = "10.1038/gim.2015.184",
language = "English (US)",
volume = "18",
pages = "863--868",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses

AU - Haraldsdottir, Sigurdis

AU - Hampel, Heather

AU - Wu, Christina

AU - Weng, Daniel Y.

AU - Shields, Peter G.

AU - Frankel, Wendy L.

AU - Pan, Xueliang

AU - De La Chapelle, Albert

AU - Goldberg, Richard M.

AU - Bekaii-Saab, Tanios

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Purpose:Mismatch repair-deficient (dMMR) colorectal cancer (CRC) is caused by Lynch syndrome (LS) in 3% and sporadic inactivation of MLH1 by hypermethylation (MLH1-hm) in 12% of cases. It is not clear whether outcomes between LS-associated and MLH1-hm CRC differ. The objective of this study was to explore differences in clinical factors and outcomes in these two groups.Methods:Patients with dMMR CRC identified by immunohistochemistry staining and treated at a single institution from 1998 to 2012 were included. MLH1-hm was established with BRAF mutational analysis or hypermethylation testing. Patients' charts were accessed for information on pathology, germ-line MMR mutation testing, and clinical course.Results:A total of 143 patients had CRC associated with LS (37 patients, 26%) or MLH1-hm (106 patients, 74%). Patients with LS were younger, more often male, presented more often with stage III disease, and had more metachronous disease than patients with MLH1-hm tumors. There was no difference in cancer-specific survival (CSS) between the groups; overall survival was longer in patients with LS, but this difference was minimal after adjusting for age and stage at diagnosis.Conclusion:CSS did not differ in LS-associated CRC compared with MLH1-hm CRC, suggesting that they carry a similar prognosis.

AB - Purpose:Mismatch repair-deficient (dMMR) colorectal cancer (CRC) is caused by Lynch syndrome (LS) in 3% and sporadic inactivation of MLH1 by hypermethylation (MLH1-hm) in 12% of cases. It is not clear whether outcomes between LS-associated and MLH1-hm CRC differ. The objective of this study was to explore differences in clinical factors and outcomes in these two groups.Methods:Patients with dMMR CRC identified by immunohistochemistry staining and treated at a single institution from 1998 to 2012 were included. MLH1-hm was established with BRAF mutational analysis or hypermethylation testing. Patients' charts were accessed for information on pathology, germ-line MMR mutation testing, and clinical course.Results:A total of 143 patients had CRC associated with LS (37 patients, 26%) or MLH1-hm (106 patients, 74%). Patients with LS were younger, more often male, presented more often with stage III disease, and had more metachronous disease than patients with MLH1-hm tumors. There was no difference in cancer-specific survival (CSS) between the groups; overall survival was longer in patients with LS, but this difference was minimal after adjusting for age and stage at diagnosis.Conclusion:CSS did not differ in LS-associated CRC compared with MLH1-hm CRC, suggesting that they carry a similar prognosis.

KW - colorectal cancer

KW - deficient mismatch repair system

KW - hypermethylation

KW - Lynch syndrome

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84984982048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984982048&partnerID=8YFLogxK

U2 - 10.1038/gim.2015.184

DO - 10.1038/gim.2015.184

M3 - Article

VL - 18

SP - 863

EP - 868

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 9

ER -